Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Rating of “Moderate Buy” from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has been assigned a consensus rating of “Moderate Buy” from the twenty-two ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $190.6316.

A number of brokerages recently commented on ALAB. Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Citigroup reiterated an “outperform” rating on shares of Astera Labs in a research note on Tuesday, December 9th. Bank of America began coverage on shares of Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price for the company. Northland Securities increased their price target on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd.

Astera Labs Trading Down 3.8%

Shares of ALAB stock opened at $169.66 on Friday. The stock has a market cap of $28.66 billion, a P/E ratio of 152.85, a price-to-earnings-growth ratio of 2.31 and a beta of 1.50. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The stock has a 50 day simple moving average of $161.80 and a 200 day simple moving average of $169.34.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Analysts forecast that Astera Labs will post 0.34 EPS for the current year.

Insider Buying and Selling

In related news, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the sale, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at $27,823,452.93. This trade represents a 5.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares of the company’s stock, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 576,936 shares of company stock worth $87,409,540. 12.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently made changes to their positions in the stock. Assetmark Inc. increased its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Hilltop National Bank grew its stake in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new position in shares of Astera Labs during the fourth quarter worth $33,000. Bernard Wealth Management Corp. acquired a new position in shares of Astera Labs during the second quarter worth $36,000. Finally, National Bank of Canada FI lifted its stake in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.